igeahub.com
Top Pharma News of the Week - IgeaHub
FibroGen Announces Positive Topline Results from Phase 2 Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis Aug. 07, 2017 FibroGen, Inc., a